Stocks · News reference
Agilent Technologies has finalized its acquisition of Proscia, a provider of digital pathology software, for $240 million in cash plus potential performance-based earn-outs.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Agilent Technologies has introduced the 5987A single quadrupole mass selective detector (MSD) with GC Assist and MassHunter 14 software to enhance laboratory efficiency and data quality.
Agilent Technologies, Inc. has scheduled the release of its fourth-quarter fiscal year 2026 financial results for November 23, 2026.
Evercore ISI has revised its price target for Agilent Technologies, lowering it from $178 to $172.
Thailand's NGS market is projected to reach $305.21 million by 2036, growing at a 12.7% CAGR from $92.03 million in 2026. Growth is driven by the Genomics Thailand national precision medicine initiative, rising clinical adoption in oncology and rare diseases, expanded reimbursement under the Universal Coverage Scheme, and increasing demand for outsourced sequencing services. Commercial sequencing services and clinical applications in oncology are expected to be the fastest-growing segments.
Agilent Technologies and the University of Chicago have established a new Center of Excellence (CoE) for Energy Materials Research at the Pritzker School of Molecular Engineering.
Deutsche Bank has initiated coverage on Agilent Technologies, Inc. with a Buy rating and a price target of $190.